"Commander Manuel Fajardo Rivero" Hospital
Havana, La Habana, 10400, Cuba
NCT Number: NCT00978887
The purpose of the study is to assess the efficacy of Retorna facial cream usage in the reduction or total correction of facial wrinkles. The duration of this double-blind placebo controlled phase 3 clinical trial will be 4 weeks. The estimated number of women to be recruited and randomized for the study is 148. Occurrence of adverse effects will also be evaluated.
Looking for future studies?
Notify Me20 year–60 year
Female
Interventional
Phase 3
Havana, La Habana, 10400, Cuba
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dosage commensurate with surface to be treated, Retorna facial cream (Topical use), twice a day, for 4 weeks.
Dosage commensurate with surface to be treated, Placebo facial cream (Topical use), twice a day, for 4 weeks
Time frame: 4 weeks
Time frame: 4 weeks
Catalysis SL
Industry
Efficacy of Retorna Facial Cream Usage in the Treatment of Facial Wrinkles
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07618468
Facial Wrinkles, Lipid Metabolism Disorders
Moscow, Russia
View Trial DetailsNCT07617350
Facial Lipoatrophy, Facial Wrinkles
Moscow, Russia
View Trial DetailsNCT07572331
Acne, Acne Vulgaris
Beverly, Massachusetts, United States
View Trial DetailsNCT06657365
Anti-Aging, Facial Wrinkles
Beijing, China
View Trial Details